Faricimab Completed Phase 2 Trials for Diabetic Macular Edema (DME) Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT04597918 | A Study to Investigate Aqueous Humor and Multimodal Imaging Biomarkers in Treatment-Naïve Participants With Diabetic Macular Edema Treated With Faricimab | |
| NCT02699450 | A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema |